SMS Pharmaceuticals Limited (NSE:SMSPHARMA)

SMS Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	363.13	458.77	413.99	360.4	73.08	465.83
Short-Term Investments	-	0.96	0.91	0.77	0.7	-
Cash & Short-Term Investments	363.13	459.73	414.91	361.16	73.78	465.83
Cash Growth	-63.57%	10.80%	14.88%	389.52%	-84.16%	15.24%
Accounts Receivable	2,433	2,159	2,032	2,362	1,483	485.19
Other Receivables	-	145.8	153.68	118.59	171.14	182.27
Receivables	2,433	2,304	2,186	2,481	1,655	667.46
Inventory	3,777	3,512	2,847	2,337	2,235	2,511
Prepaid Expenses	-	54.43	70.52	52.54	49.33	33.07
Other Current Assets	283.79	49.44	25.95	107.35	93.78	93.17
Total Current Assets	6,857	6,380	5,545	5,339	4,106	3,771
Property, Plant & Equipment	7,177	6,529	5,655	4,649	4,437	4,476
Long-Term Investments	275.9	262.83	116.79	109.38	105.22	215.27
Other Intangible Assets	30.3	27.96	21.3	26.6	14.66	13.7
Other Long-Term Assets	265.71	424.9	188.85	217.3	132.32	119.28
Total Assets	14,606	13,624	11,527	10,341	8,796	8,595

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,705	1,204	1,139	1,513	1,074	649.92
Accrued Expenses	-	218.42	201.46	124.22	85.06	118.26
Short-Term Debt	-	1,509	1,248	1,140	937.89	679.12
Current Portion of Long-Term Debt	1,963	425.04	465.92	440.96	375.91	427
Current Portion of Leases	-	-	-	5.92	9.4	10.4
Current Income Taxes Payable	18.59	6.15	-	-	-	-
Current Unearned Revenue	-	8.72	4.82	19.77	-	-
Other Current Liabilities	425.31	158.06	184.33	73.12	66.58	80.09
Total Current Liabilities	4,112	3,530	3,244	3,317	2,549	1,965
Long-Term Debt	1,531	1,716	1,394	1,221	1,211	1,495
Long-Term Leases	-	-	-	-	6.14	21.14
Pension & Post-Retirement Benefits	-	-	2.57	3.78	8.04	9.94
Long-Term Deferred Tax Liabilities	520.48	508.15	480.98	427.99	410.2	395.51
Other Long-Term Liabilities	15.75	11.99	9.49	7.82	6.01	5.73
Total Liabilities	6,180	5,766	5,130	4,978	4,191	3,892

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	93.65	93.65	88.65	84.65	84.65	84.65
Additional Paid-In Capital	-	1,832	1,202	698.18	698.18	698.18
Retained Earnings	-	5,917	4,931	4,279	3,807	3,905
Comprehensive Income & Other	8,333	15.5	174.25	301.25	15.5	15.5
Total Common Equity	8,427	7,858	6,396	5,363	4,605	4,703
Minority Interest	-	0	0	-	-	-
Shareholders' Equity	8,427	7,858	6,396	5,363	4,605	4,703
Total Liabilities & Equity	14,606	13,624	11,527	10,341	8,796	8,595

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	3,495	3,650	3,108	2,808	2,541	2,633
Net Cash (Debt)	-3,132	-3,191	-2,693	-2,447	-2,467	-2,167
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-33.46	-34.90	-31.79	-28.90	-29.14	-25.60
Filing Date Shares Outstanding	93.55	93.65	88.65	84.65	84.65	84.65
Total Common Shares Outstanding	93.55	93.65	88.65	84.65	84.65	84.65
Working Capital	2,745	2,850	2,301	2,022	1,557	1,806
Book Value Per Share	90.08	83.91	72.15	63.36	54.40	55.56
Tangible Book Value	8,397	7,830	6,375	5,337	4,591	4,689
Tangible Book Value Per Share	89.76	83.61	71.91	63.04	54.23	55.39
Land	-	51.87	42.13	42.13	42.13	42.13
Buildings	-	1,653	1,566	1,341	1,308	1,300
Machinery	-	6,200	5,905	4,841	4,331	4,279
Construction In Progress	-	1,216	346.71	302.72	331.91	110.04

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error